Natural Product: NPC200221

Natural Product IDNPC200221
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
2-Hydroxy-1-Methoxyxanthone
IUPAC Name 2-hydroxy-1-methoxyxanthen-9-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1923834
PubChem CID 10399460
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ATPZBKJDXXSOFC-UHFFFAOYSA-N
Standard InCHI InChI=1S/C14H10O4/c1-17-14-9(15)6-7-11-12(14)13(16)8-4-2-3-5-10(8)18-11/h2-7,15H,1H3
SMILES COc1c(ccc2c1c(=O)c1ccccc1o2)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   242.06 Volume:   241.737
?
Van der Waals volume.
Dense:   1.001 LogP:   2.429
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.437
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.811
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   1.0 Rigid Bonds:   17.0
TPSA:   59.67
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   1.0 Rings:   3.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.666 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.118 Fsp3:   0.071
MCE-18:   16.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.169 Fluc inhibitor:   0.845
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.769
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.525
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.642 Promiscuous compounds:   0.386

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.806 MDCK Permeability:   -4.652
Pgp-inhibitor:   0.398 Pgp-substrate:   0.105
PAMPA:   0.299
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.098
20% Bioavailability (F20%):   0.449 30% Bioavailability (F30%):   0.781
50% Bioavailability (F50%):   0.96

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.016 MRP1:   0.874
Plasma Protein Binding (PPB):   91.114% Volume Distribution (VD):   -0.329
Fu: 9.871%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.928
OATP1B3 inhibitor:   0.997 BCRP inhibitor:   0.954
BSEP inhibitor:   0.927

ADMET: Metabolism

CYP1A2-inhibitor:   0.975 CYP1A2-substrate:   0.902
CYP2C19-inhibitor:   0.239 CYP2C19-substrate:   0.59
CYP2C9-inhibitor:   0.983 CYP2C9-substrate:   0.01
CYP2D6-inhibitor:   0.967 CYP2D6-substrate:   0.415
CYP3A4-inhibitor:   0.012 CYP3A4-substrate:   0.239
CYP2B6-substrate:   0.52 CYP2C8-inhibitor:   0.034
HLM stability:   0.533
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.306 Half-life (T1/2):  1.209

ADMET: Toxicity

hERG Blockers:  0.093 hERG Blockers (10um):  0.479
Human Hepatotoxicity (H-HT):  0.5 Drug-induced Liver Injury (DILI):  0.806
AMES Toxicity:  0.631 Rat Oral Acute Toxicity:  0.473
Maximum Recommended Daily Dose:  0.408 Skin Sensitization:  0.574
Carcinogencity:  0.818 Eye Corrosion:  0.446
Eye Irritation:  0.987 Respiratory Toxicity:  0.745
Drug-induced Neurotoxicity:  0.214 Ototoxicity:  0.125
Hematotoxicity:  0.252 Drug-induced Nephrotoxicity:  0.153
Genotoxicity:  0.451 RPMI-8226 Immunitoxicity:  0.065
A549 Cytotoxicity:  0.133 Hek293 Cytotoxicity:  0.272
BCF:   1.13
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.826
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.764
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.379
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40174 Kielmeyera variabilis Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[26900954]
NPO18656 Iphigenia indica Species Colchicaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO18656 Iphigenia indica Species Colchicaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18656 Iphigenia indica Species Colchicaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18656 Iphigenia indica Species Colchicaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO18656 Iphigenia indica Species Colchicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO19688 Mangifera odorata Species Anacardiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27687 Peliosanthes sinica Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20 Organism Candida albicans Candida albicans MIC = 31.3 ug.mL-1 PMID[22014830]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 125.0 ug.mL-1 PMID[22014830]
NPT85 Organism Filobasidiella neoformans Cryptococcus neoformans MIC = 15.6 ug.mL-1 PMID[22014830]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 64.0 ug.mL-1 PMID[26900954]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 128.0 ug.mL-1 PMID[26900954]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 32.0 ug.mL-1 PMID[26900954]
NPT314 Organism Bacillus cereus Bacillus cereus MIC = 31.3 ug.mL-1 PMID[22014830]
NPT1140 Organism Escherichia coli ATCC 8739 Escherichia coli ATCC 8739 MIC = 125.0 ug.mL-1 PMID[22014830]
NPT1121 Organism Moraxella catarrhalis Moraxella catarrhalis MIC = 125.0 ug.mL-1 PMID[22014830]
NPT1101 Organism Staphylococcus aureus subsp. aureus RN4220 Staphylococcus aureus subsp. aureus RN4220 MIC = 64.0 ug.mL-1 PMID[26900954]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC200221 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7143 Intermediate Similarity NPC611763
0.6939 Remote Similarity NPC161277
0.64 Remote Similarity NPC292214
0.64 Remote Similarity NPC92564
0.6327 Remote Similarity NPC608827
0.6275 Remote Similarity NPC608745
0.6078 Remote Similarity NPC610896
0.6038 Remote Similarity NPC120537
0.5849 Remote Similarity NPC294502
0.5849 Remote Similarity NPC271779
0.5833 Remote Similarity NPC278787
0.5769 Remote Similarity NPC145673
0.5769 Remote Similarity NPC17055
0.5636 Remote Similarity NPC285144
0.56 Remote Similarity NPC605893
0.5556 Remote Similarity NPC88645
0.551 Remote Similarity NPC601623
0.551 Remote Similarity NPC602252
0.549 Remote Similarity NPC231013
0.5476 Remote Similarity NPC475269
0.5476 Remote Similarity NPC35744
0.537 Remote Similarity NPC209278
0.52 Remote Similarity NPC606736

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC200221 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data